Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep 24;79(1):179–184. doi: 10.1038/sj.bjc.6690030

Expression of midkine in the early stage of carcinogenesis in human colorectal cancer

C Ye 1, M Qi 2, Q-W Fan 2, K Ito 3, S Akiyama 3, Y Kasai 3, M Matsuyama 1, T Muramatsu 2, K Kadomatsu 2
PMCID: PMC2362182  PMID: 10408712

Abstract

It has been suggested that a heparin-binding growth factor, midkine (MK), plays an important role incarcinogenesis because of its frequent overexpression in various malignant tumours. To clarify whether or not MK contributes to theearly stage of carcinogenesis, we examined the status of MK mRNA in 20 adenomas with moderate- and severe-grade dysplasia, 28carcinomas and 28 corresponding normal tissues, by means of Northern blotting. The MK expression level was significantly moreelevated in adenomas than in normal tissues P< 0.001, unpaired Student's t -test). A difference wasalso observed between carcinomas and the corresponding normal tissues P< 0.04, paired Student's t-test). Moreover, MK immunostaining was positive in the adenomas with moderate- and severe-grade dysplasia and in the carcinomas,but not in mild-grade dysplasia or in normal tissues. These findings were in line with those on Western blotting. In three patientswith both adenomas with moderate- or severe-grade dysplasia and carcinomas, elevated MK expression was observed in the neoplasticlesions. This is the first report of the association of elevated MK expression with the early stage of carcinogenesis in humans. © 1999 Cancer Research Campaign

Keywords: carcinogenesis, colorectal adenoma, colorectal carcinoma, midkine, pleiotrophin

Full Text

The Full Text of this article is available as a PDF (579.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTLER V. B., COLLER F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954 Jun;139(6):846–852. doi: 10.1097/00000658-195406000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aaronson S. A. Growth factors and cancer. Science. 1991 Nov 22;254(5035):1146–1153. doi: 10.1126/science.1659742. [DOI] [PubMed] [Google Scholar]
  3. Adachi Y., Matsubara S., Pedraza C., Ozawa M., Tsutsui J., Takamatsu H., Noguchi H., Akiyama T., Muramatsu T. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene. 1996 Nov 21;13(10):2197–2203. [PubMed] [Google Scholar]
  4. Aridome K., Tsutsui J., Takao S., Kadomatsu K., Ozawa M., Aikou T., Muramatsu T. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res. 1995 Jul;86(7):655–661. doi: 10.1111/j.1349-7006.1995.tb02449.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Choudhuri R., Zhang H. T., Donnini S., Ziche M., Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 1997 May 1;57(9):1814–1819. [PubMed] [Google Scholar]
  6. Cross M., Dexter T. M. Growth factors in development, transformation, and tumorigenesis. Cell. 1991 Jan 25;64(2):271–280. doi: 10.1016/0092-8674(91)90638-f. [DOI] [PubMed] [Google Scholar]
  7. Daughaday W. H., Deuel T. F. Tumor secretion of growth factors. Endocrinol Metab Clin North Am. 1991 Sep;20(3):539–563. [PubMed] [Google Scholar]
  8. Dawson T., Wynford-Thomas D. Does autocrine growth factor secretion form part of a mechanism which paradoxically protects against tumour development? Br J Cancer. 1995 Jun;71(6):1136–1141. doi: 10.1038/bjc.1995.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Garver R. I., Jr, Chan C. S., Milner P. G. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol. 1993 Nov;9(5):463–466. doi: 10.1165/ajrcmb/9.5.463. [DOI] [PubMed] [Google Scholar]
  10. Garver R. I., Jr, Radford D. M., Donis-Keller H., Wick M. R., Milner P. G. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer. 1994 Sep 1;74(5):1584–1590. doi: 10.1002/1097-0142(19940901)74:5<1584::aid-cncr2820740514>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Hughes C. J., Reed J. A., Cabal R., Huvos A. G., Albino A. P., Schantz S. P. Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg. 1994 Nov;168(5):381–385. doi: 10.1016/s0002-9610(05)80080-7. [DOI] [PubMed] [Google Scholar]
  12. Kadomatsu K., Anzano M. A., Slayter M. V., Winokur T. S., Smith J. M., Sporn M. B. Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res. 1993 Apr 1;53(7):1480–1483. [PubMed] [Google Scholar]
  13. Kadomatsu K., Hagihara M., Akhter S., Fan Q. W., Muramatsu H., Muramatsu T. Midkine induces the transformation of NIH3T3 cells. Br J Cancer. 1997;75(3):354–359. doi: 10.1038/bjc.1997.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kadomatsu K., Huang R. P., Suganuma T., Murata F., Muramatsu T. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol. 1990 Mar;110(3):607–616. doi: 10.1083/jcb.110.3.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kadomatsu K., Tomomura M., Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988 Mar 30;151(3):1312–1318. doi: 10.1016/s0006-291x(88)80505-9. [DOI] [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Michikawa M., Kikuchi S., Muramatsu H., Muramatsu T., Kim S. U. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J Neurosci Res. 1993 Aug 1;35(5):530–539. doi: 10.1002/jnr.490350509. [DOI] [PubMed] [Google Scholar]
  18. Muramatsu H., Muramatsu T. Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun. 1991 Jun 14;177(2):652–658. doi: 10.1016/0006-291x(91)91838-4. [DOI] [PubMed] [Google Scholar]
  19. Muramatsu H., Shirahama H., Yonezawa S., Maruta H., Muramatsu T. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol. 1993 Oct;159(2):392–402. doi: 10.1006/dbio.1993.1250. [DOI] [PubMed] [Google Scholar]
  20. Muramatsu T. Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol. 1993 Mar;37(1):183–188. [PubMed] [Google Scholar]
  21. Nakagawara A., Milbrandt J., Muramatsu T., Deuel T. F., Zhao H., Cnaan A., Brodeur G. M. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res. 1995 Apr 15;55(8):1792–1797. [PubMed] [Google Scholar]
  22. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6133–6137. doi: 10.1073/pnas.82.18.6133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nurcombe V., Fraser N., Herlaar E., Heath J. K. MK: a pluripotential embryonic stem-cell-derived neuroregulatory factor. Development. 1992 Dec;116(4):1175–1183. doi: 10.1242/dev.116.4.1175. [DOI] [PubMed] [Google Scholar]
  24. O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A. L. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 1996 Jun 1;56(11):2515–2518. [PubMed] [Google Scholar]
  25. Pitot H. C., Dragan Y. P., Teeguarden J., Hsia S., Campbell H. Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol. 1996 Jan-Feb;24(1):119–128. doi: 10.1177/019262339602400116. [DOI] [PubMed] [Google Scholar]
  26. Sandgren E. P., Luetteke N. C., Qiu T. H., Palmiter R. D., Brinster R. L., Lee D. C. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol. 1993 Jan;13(1):320–330. doi: 10.1128/mcb.13.1.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sporn M. B., Todaro G. J. Autocrine secretion and malignant transformation of cells. N Engl J Med. 1980 Oct 9;303(15):878–880. doi: 10.1056/NEJM198010093031511. [DOI] [PubMed] [Google Scholar]
  28. Tamano S., Merlino G. T., Ward J. M. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis. 1994 Sep;15(9):1791–1798. doi: 10.1093/carcin/15.9.1791. [DOI] [PubMed] [Google Scholar]
  29. Tomomura M., Kadomatsu K., Matsubara S., Muramatsu T. A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem. 1990 Jun 25;265(18):10765–10770. [PubMed] [Google Scholar]
  30. Tomomura M., Kadomatsu K., Nakamoto M., Muramatsu H., Kondoh H., Imagawa K., Muramatsu T. A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity. Biochem Biophys Res Commun. 1990 Sep 14;171(2):603–609. doi: 10.1016/0006-291x(90)91189-y. [DOI] [PubMed] [Google Scholar]
  31. Tsutsui J., Kadomatsu K., Matsubara S., Nakagawara A., Hamanoue M., Takao S., Shimazu H., Ohi Y., Muramatsu T. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res. 1993 Mar 15;53(6):1281–1285. [PubMed] [Google Scholar]
  32. Unoki K., LaVail M. M. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):907–915. [PubMed] [Google Scholar]
  33. Yang D., Alt E., Rogler C. E. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res. 1993 May 1;53(9):2020–2027. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES